Skip to main content
Feedback to SSRN
Feedback
(required)
Email
(required)
Submit
Bo Zhang
General Hospital of Central Theater Command - Department of Infectious Disease
Learn more about SSRN Profiles
SCHOLARLY PAPERS
1
DOWNLOADS
122
TOTAL CITATIONS
7
Feedback
Scholarly Papers (1)
Sort by:
Paper Title, A-Z
Paper Title, Z-A
Author Name, A-Z
Author Name, Z-A
Date Posted, Ascending
Date Posted, Descending
Downloads, Ascending
Downloads, Descending
Citations, Ascending
Citations, Descending
Actions:
Email selected abstracts
View:
Selected
Original List
All Versions
Hide All Versions
All Abstracts
Hide All Abstracts
(Rank)
1.
Treatment with Human Umbilical Cord-Derived Mesenchymal Stem Cells for Severe COVID-19 Patients with Lung Damage: A Randomised, Double-Blind, Placebo‑Controlled Phase 2 Trial
Number of pages: 36
Posted: 14 Oct 2020
Lei Shi
,
Hai Huang
,
Xuechun Lu
,
Xiaoyan Yan
,
Xiaojing Jiang
,
Ruonan Xu
,
Siyu Wang
,
Chao Zhang
,
Xin Yuan
,
Zhe Xu
,
Lei Huang
,
Jun-Liang Fu
,
Yuanyuan Li
,
Yu Zhang
,
Wei Qi Yao
,
Tianyi Liu
,
Jinwen Song
,
Liangliang Sun
,
Fan Yang
,
Xin Zhang
, Bo Zhang,
Ming Shi
,
Fanping Meng
,
Yanning Song
,
Yongpei Yu
,
Jiqiu Wen
,
Qi Li
,
Qing Mao
,
Chen Yao
,
Wei-fen Xie
and
Fu-Sheng Wang
Government of the People's Republic of China - Treatment and Research Center for Infectious Diseases, Second Military Medical University - Department of Respiratory, Wuhan Huoshenshan Hospital, Peking University - Clinical Research Institute, General Hospital of Central Theater Command - Department of Infectious Disease, Government of the People's Republic of China - Treatment and Research Center for Infectious Diseases, Government of the People's Republic of China - Treatment and Research Center for Infectious Diseases, Government of the People's Republic of China - Treatment and Research Center for Infectious Diseases, Government of the People's Republic of China - Treatment and Research Center for Infectious Diseases, Government of the People's Republic of China - Fifth Medical Center of Chinese PLA General Hospital, Government of the People's Republic of China - Treatment and Research Center for Infectious Diseases, Chinese PLA General - Department of Infectious Diseases, Government of the People's Republic of China - Treatment and Research Center for Infectious Diseases, Wuhan Huoshenshan Hospital, Huazhong University of Science and Technology - Department of Hematology, Wuhan Huoshenshan Hospital, Government of the People's Republic of China - Treatment and Research Center for Infectious Diseases, Government of the People's Republic of China - Department of Endocrinology and Metabolism, Huazhong University of Science and Technology - Department of Radiology, Wuhan Huoshenshan Hospital, General Hospital of Central Theater Command - Department of Infectious Disease, Government of the People's Republic of China - Treatment and Research Center for Infectious Diseases, Government of the People's Republic of China - General Hospital of Beijing Military Region, Chinese PLA General Hospital - Department of Infectious Diseases, Peking University - Clinical Research Institute, Wuhan Huoshenshan Hospital, Wuhan Huoshenshan Hospital, Wuhan Huoshenshan Hospital, Peking University - Clinical Research Institute, Government of the People's Republic of China - Department of Gastroenterology and Government of the People's Republic of China - Treatment and Research Center for Infectious Diseases
Downloads
122
(495,865)
Citation
7
View PDF
Download
Abstract:
COVID-19, Mesenchymal stem cells, Randomised controlled trial
Feedback